CureVac N.V. Profile Avatar - Palmy Investing

CureVac N.V.

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in…
Biotechnology
DE, Tübingen [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

CureVac N.V. has no acquisition track records yet.

M&A Deals · History

CureVac N.V. has no acquisition track records yet.

M&A Deals · Within Industry

No current deals within Biotechnology Industry.

M&A Deals · Latest

Act, dont react; Track the most urgent M&A deals across all industries

Details
Owens Corning
Debt
Agg. Maximum Price
$373,155,000.00
SOLO BRANDS, INC.
Details
?
Equity
Agg. Maximum Price
$n/a
JET.AI INC.
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
?
Equity
Agg. Maximum Price
$2,264,484.00
BELLEVUE LIFE SCIENCES ACQUISITION CORP.
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
?
Equity
Agg. Maximum Price
$381.73
BURTECH ACQUISITION CORP.
Details
?
Equity
Agg. Maximum Price
$7,657,428.54
PEAK BIO, INC.
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
?
Equity
Agg. Maximum Price
$19,377,844.50
ALTENERGY ACQUISITION CORP.
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00
American International Group, Inc.